Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers.
about
Aag DNA glycosylase promotes alkylation-induced tissue damage mediated by Parp1Association of DNA Repair Gene APE1 Asp148Glu Polymorphism with Breast Cancer Risk.Identification of a novel potential antitumor activity of gossypol as an APE1/Ref-1 inhibitor.Prognostic value of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in breast cancer.Prediction of Lymph Node Metastases in Gastric Cancer by Serum APE1 ExpressionTumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy.APE1/Ref-1 as an emerging therapeutic target for various human diseases: phytochemical modulation of its functionsDevelopment and evaluation of human AP endonuclease inhibitors in melanoma and glioma cell linesHaplotypes of DNA repair and cell cycle control genes, X-ray exposure, and risk of childhood acute lymphoblastic leukemia.Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer.An APE1 inhibitor reveals critical roles of the redox function of APE1 in KSHV replication and pathogenic phenotypesBalancing repair and tolerance of DNA damage caused by alkylating agentsAT101 exerts a synergetic efficacy in gastric cancer patients with 5-FU based treatment through promoting apoptosis and autophagy.Human apurinic/apyrimidinic endonuclease 1.Association of nuclear annexin A1 with prognosis of patients with esophageal squamous cell carcinoma.Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers.Apurinic/apyrimidinic endonuclease 1 (APE1/Ref-1) overexpression is an independent prognostic marker in prostate cancer without TMPRSS2:ERG fusion.Impact of apurinic/apyrimidinic endonuclease 1/redox factor-1 on treatment response and survival in oral squamous cell carcinoma.Receptor-based virtual screening and biological characterization of human apurinic/apyrimidinic endonuclease (Ape1) inhibitors.Design and synthesis of 3-carbamoylbenzoic acid derivatives as inhibitors of human apurinic/apyrimidinic endonuclease 1 (APE1).Biodegradable DNA-enabled poly(ethylene glycol) hydrogels prepared by copper-free click chemistry.Deregulation of base excision repair gene expression and enhanced proliferation in head and neck squamous cell carcinoma.Abasic and oxidized ribonucleotides embedded in DNA are processed by human APE1 and not by RNase H2.APE1/Ref-1 knockdown in pancreatic ductal adenocarcinoma - characterizing gene expression changes and identifying novel pathways using single-cell RNA sequencing.Apurinic/apyrimidinic endonuclease 1 (APE1) is overexpressed in malignant transformation of salivary gland pleomorphic adenoma.Placental type alkaline phosphatase tissue expression in ovarian serous carcinoma.Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic.Dysregulation of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in advanced retinoblastoma.Prognostic significance of APE1 cytoplasmic localization in human epithelial ovarian cancer.DNA damage repair in ovarian cancer: unlocking the heterogeneity.Dysregulated Expression and Subcellular Localization of Base Excision Repair (BER) Pathway Enzymes in Gallbladder Cancer
P2860
Q27323759-64026015-DE20-43A4-A210-02E0C90548ADQ30377712-99555B15-0C79-4416-B31F-5492EE3EA1CAQ33632423-F557A747-83F8-49A5-8D0A-012D0CE42AF0Q33734346-FA5AE69A-03CD-4C91-92EA-BD49438D202BQ33820896-47025546-B974-4456-8F76-6EB58F93DD83Q33903723-4CEEF3B4-B985-4AAC-90B6-76FB92D609EAQ33990581-B95EAA23-5681-4AF9-A03D-C3A8C8C0543BQ34627873-88EB94F8-EF69-4398-9EC8-94687DC12F27Q35501750-FCF6B962-7466-4D63-B406-0C3EBBDCFC53Q35743521-2BBC6054-DCF3-40D8-9579-ABDD5CADBECFQ36336086-0F725525-1FAA-4627-8435-B43BADB95F8AQ36651488-68F82D60-B1B9-47A5-BC9D-B8831A7AED8DQ37376289-637BF678-D8DB-493F-8E1A-57BB0DDC738BQ37512952-3544A3ED-A9CC-498F-93DF-62013B878B90Q37587416-D8318B95-9277-4DF5-B416-B6815630121CQ37933098-74479FE3-C638-44A1-98A5-22EE7E9DED8BQ38807025-5692ECA2-09C1-45ED-80E8-81E67FE75B9AQ38931527-F72BA127-CD2B-4D55-B0A7-53B00DED976DQ39251743-77434AB1-DAE2-4768-9567-B47A1C0376E5Q39284845-22C4F607-0DB4-4B23-9448-BFEA1601DD01Q40351814-5D7A5AED-D67E-4C4F-91F3-0C03A17DDB94Q44101885-EB85F113-7934-47CB-BBD0-9072AEAB4DACQ46754854-2B3230F8-0617-4DA7-B98D-D4F193EE702AQ47142505-15EE739B-5984-4049-90EB-D5A97F0D05D4Q50993143-39F265CA-991E-459F-98A6-1DCB6973E656Q51351089-15A9BF91-AA60-4ADC-B922-881229FB68CBQ51825149-E1BDEB4C-BCE7-44BF-A759-812C68D8435DQ53097346-88C9112F-41F1-4856-9DCD-CF90EBF0F071Q53155527-496A25E8-1613-4997-B71F-0D897A23484DQ55399645-74B2DBDC-9CA3-4A66-8CD8-08577C6117DDQ57146599-0A3E85DE-4D07-4665-8406-0FF6323D5865
P2860
Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Human apurinic/apyrimidinic en ...... d pancreatico-biliary cancers.
@ast
Human apurinic/apyrimidinic en ...... d pancreatico-biliary cancers.
@en
type
label
Human apurinic/apyrimidinic en ...... d pancreatico-biliary cancers.
@ast
Human apurinic/apyrimidinic en ...... d pancreatico-biliary cancers.
@en
prefLabel
Human apurinic/apyrimidinic en ...... d pancreatico-biliary cancers.
@ast
Human apurinic/apyrimidinic en ...... d pancreatico-biliary cancers.
@en
P2093
P2860
P50
P356
P1476
Human apurinic/apyrimidinic en ...... nd pancreatico-biliary cancers
@en
P2093
A Al-Attar
A M Zaitoun
K R Fareed
M Mohammed
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605541
P407
P577
2010-01-19T00:00:00Z
P5875
P6179
1002297623